Raymond James Keeps Their Buy Rating on Medtronic (MDT)
In a report released today, Jayson Bedford from Raymond James maintained a Buy rating on Medtronic (MDT), with a price target of $118. The company’s shares closed last Monday at $106.91, close to its 52-week high of $109.70.
According to TipRanks.com, Bedford is a top 100 analyst with an average return of 15.7% and a 69.6% success rate. Bedford covers the Healthcare sector, focusing on stocks such as Boston Scientific Corp, Edwards Lifesciences, and Nuvectra Corporation.
Medtronic has an analyst consensus of Strong Buy, with a price target consensus of $113.07, implying a 4.7% upside from current levels. In a report issued on August 14, Cowen & Co. also maintained a Buy rating on the stock with a $111 price target.
See today’s analyst top recommended stocks >>
The company has a one-year high of $109.70 and a one-year low of $81.66. Currently, Medtronic has an average volume of 4.91M.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.